Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research as project coordinator, London School of Hygiene & Tropical Medicine , Le Centre Muraz , Inserm Transfert and the Janssen Pharmaceutical Companies of Johnson & Johnson .